AKUT BRONŞİYOLİTLİ OLGULARIN RETROSPEKTİF DEĞERLENDİRİLMESİ

Year 2005, Volume: 6 Issue: 3, 29 - 32, 01.12.2005

Hacer Ergin Erol Dağdeviren Aziz Polat İlknur Kılıç Serap Semiz Mine Cinbiş

Abstract

Amaç:Bronşiolit, küçük hava yollarının inflamatuar obstrüksiyonundan kaynaklanan ve özellikle 6 aydan küçükçocuklarda en sık hospitalizasyon nedeni olan bir hastalıktır. Bu çalışmada, kliniğimize bronşiolit nedeniylekabul edilen olguların demografik özellikleri, klinik bulguları, tedavisi ve prognozu analiz edildi.Bulgular:Olguların %59,7'si (n=40) erkek, %40,3'ü (n=37) kız olup, %40,3'ü kış, %29,9'u ilkbahar, %23,9'usonbahar, %6'sı yaz mevsiminde hastanemize kabul edildi. En büyük hasta gurubunu 3-6 aylık bebekler (%35,8)oluşturmaktaydı. İlk başvuru şikayetleri %85'inde öksürük, %53,7'sinde hırıltı ve %34,3'ünde ateşti. Atopiöyküsü üç ve daha fazla atak geçirenlerde %41.6, bir ve iki atak geçirenlerde %20 olarak saptandı.Sonuç:Ailede atopi öyküsü bulunmasının bronşiolitli olgularda atak sayısını ve steroid gereksinimini arttırdığıgörüldü

Keywords

Bronşiyolit, atopi, steroid

The Retrospective Evaluation Of Patients With Acute Bronchiolitis

Abstract

Bronchiolitis is an under respiratory tract disorder which is caused by the inflammatory obstruction of the
small airways. It is also the most common reason for hospitalization of children younger than 6 months. In this
study, demographic characteristics, clinical symptoms, treatment and prognoses of patients who had been
admitted to our clinic due to bronchiolitis were investigated.
59.7% of patients were male, and 40.3% were female. 40.3% were admitted to our hospital in winter,
29.5% in spring, 23.6% in fall and 6% in summer. The largest group of patients consisted of infants between 3-6
months (35.9%). Initial complaints were coughing in 85%, wheezing in 53.7% and fever in 34.3%. Of the patients
history of atopy was determined more frequently (41.6%) among those who suffered from three or more attacks
compared with patients who experienced one to two attacks (20%).
A history of atopy in the patient's family increases the number of bronchiolitis attacks and the need for
steroid.

Keywords

Bronchiolitis, atopy, steroid

References

• 1. Berger I, Argaman Z, Schwartz SB. Efficacy of corticosteroids in acute bronchiolitis: Short-term and long-term follow-up. Pediatr Pulmonol 1998;26:162-6.
• 2. Edwards G. Acute bronchitis-aetiology, diagnosis and management. Brit Med J 1966;1:963.
• 3. Carlsen KH, Orstavik I, Halvorsen K. Viral infections of the respiratory tract in hospitalized children. Acta Pediatr Scand 1983;72:53-54.
• 4. Edelson PJ. Respiratory syncytial virus pneumonia. In: Pediatric Emergency Casebook. New York: World Health Communications Inc 1985;3:1-15.
• 5. Henderson FW, Clyde WA, Collier AM, et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 1979; 95:183-190.
• 6. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infections for infants from low income families in relations to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981;98:708-715.
• 7. Wennergren G, Hansson S, Engström I, et al. Characteristics and prognosis of hospital treated obstructive bronchitis in children aged less than two years.Acta Pediat 1992;81:405.
• 8. Ertem E, Tanaç R, Çoker M. Akut bronşiolit ve respiratuar sinsisyal virüs. T Klin Pediatri 1996; 5:602.
• 9. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions. N Engl J Med 1981; 305:841-846.
• 10. Nişli K, Öneş Ü, Güler N, Tamay Z. Hışıltılı süt çocuklarında RSV antikorları, lökotrien E4 ve total IgE düzeyleri. Çocuk Dergisi 2004; 4:33-36.
• 11. McConnochie KM. Bronchiolitis. Am J Dis Child 1983; 137:11-3.
• 12. Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet 1990;335:1259-61.
• 13. Welliver JR, Welliver RC. Bronchiolitis. Pediatr Rev 1993; 14:134-9.
• 14. Wohl ME. Bronchiolitis. In: Boat T, Chernick V (eds). Kendig's Disorders of the Respiratory Tract in Children, 6th ed. Philadelphia: WB Saunders, 1998:473-85.
• 15. Kerby GS, Larsen GL, Accurso FC, Deterding RR, Balasubramaniam V, Sagel SD. Respiratory tract & mediastinum. In: Carl W. White (ed). Current Pediatric Diagnosis & Treatment (15th). USA: McGraw-Hill Companies Inc, 2005:506-508.
• 16. Penn CC, Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993; 14:645-54.
• 17. Rakshi K, Couriel JM. Management of acute bronchiolitis.Arch Dis Child 1994; 71:463-9.
• 18. McMillan JA, Tristram DA, Weiner LB, et al. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters. Pediatrics 1988; 81:22-26.
• 19. La Via WV, Marks MI, Stutman HR. Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and prevention. J Pediatr 1992;121:503-510.
• 20. Stretton M, Ajizian SJ, Mitchell I, Newth CJL. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 1992;13:143-150.
• 21. Gavin R, Anderson B, Percival T. Management of severe bronchiolitis: indications for ventilator support. NZ Med J 1996; 109:137-139.
• 22. Kellner JD, Ohlsson A, Gadomski AM, et al. Efficacy of bronchodilator therapy in bronchiolitis.Arch Pediatr Adolesc Med 1996; 150:1166-72.
• 23. King VJ, Viswanathan M, Bordley C, et al. Pharmacologic treatment of bronchiolitis in infants and children.Arch PediatrAdolesc Med 2004; 158:127-37.
• 24. Garrison MM, Christiakis DA, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: a metaanalysis. Pediatrics 2000; 105:E44.
• 25. Covar RA, Spahn JD. Treating the wheezing infant. Pediatr Clin NorthAm 2003; 50:631-54.
• 26. Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute RSV bronchiolitis. Arch Dis Child 2000; 8:126- 30.
• 27. Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of RSV infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104:E77.
• 28. Woensel JB, Kimpen JL, Sprikkelman AB, et al. Long term effects of prednisolone in the acute phase of bronchiolitis caused by RSV. Pediatr Pulmonol 2000; 30:92-6.